ScreenCell®
@screencell.bsky.social
🔬 A simple and cost-effective technology for isolating circulating tumor cells #ctcs by #liquidbiopsy 🩸
Download our brochure: https://urlr.me/23e9SA 📥
Download our brochure: https://urlr.me/23e9SA 📥
✨ Best wishes for 2026!
As the new year begins, we thank our community of researchers, clinicians, and collaborators for their trust.
In 2026, ScreenCell® will continue to advance clinical research through innovation and collaboration.
#HappyNewYear #CancerResearch #CTCs #LiquidBiopsy
As the new year begins, we thank our community of researchers, clinicians, and collaborators for their trust.
In 2026, ScreenCell® will continue to advance clinical research through innovation and collaboration.
#HappyNewYear #CancerResearch #CTCs #LiquidBiopsy
January 6, 2026 at 9:11 AM
✨ Best wishes for 2026!
As the new year begins, we thank our community of researchers, clinicians, and collaborators for their trust.
In 2026, ScreenCell® will continue to advance clinical research through innovation and collaboration.
#HappyNewYear #CancerResearch #CTCs #LiquidBiopsy
As the new year begins, we thank our community of researchers, clinicians, and collaborators for their trust.
In 2026, ScreenCell® will continue to advance clinical research through innovation and collaboration.
#HappyNewYear #CancerResearch #CTCs #LiquidBiopsy
✈️ This week, Sara SHAMDANI, Ph.D., Laboratory Manager, and Amira Mehtar, Ph.D., R&D Scientist, traveled from Paris to Canada, specifically to the Research Institute of the McGill University Health Centre (RI-MUHC) - IR-CUSM | Institut de recherche du CUSM | #ircusm - in Montreal. 🌎
December 18, 2025 at 3:51 PM
✈️ This week, Sara SHAMDANI, Ph.D., Laboratory Manager, and Amira Mehtar, Ph.D., R&D Scientist, traveled from Paris to Canada, specifically to the Research Institute of the McGill University Health Centre (RI-MUHC) - IR-CUSM | Institut de recherche du CUSM | #ircusm - in Montreal. 🌎
🔬 Can we isolate viable #CTCs for downstream applications?
Emile Lakis Ph.D ,our Technical Sales Manager, has the answer! 💡
Watch the video to see how ScreenCell MB or LCD kits enable the isolation of viable CTCs for applications like cell culture & molecular analysis. 👇
Emile Lakis Ph.D ,our Technical Sales Manager, has the answer! 💡
Watch the video to see how ScreenCell MB or LCD kits enable the isolation of viable CTCs for applications like cell culture & molecular analysis. 👇
November 25, 2025 at 9:56 AM
🔬 Can we isolate viable #CTCs for downstream applications?
Emile Lakis Ph.D ,our Technical Sales Manager, has the answer! 💡
Watch the video to see how ScreenCell MB or LCD kits enable the isolation of viable CTCs for applications like cell culture & molecular analysis. 👇
Emile Lakis Ph.D ,our Technical Sales Manager, has the answer! 💡
Watch the video to see how ScreenCell MB or LCD kits enable the isolation of viable CTCs for applications like cell culture & molecular analysis. 👇
📢 ScreenCell® kits evolving in 2026
Starting Jan 1st: standardized format across our 7 #CTC isolation kits :
✅ 2 filtration units + 1 buffer
Affecting CYTO, CSB, MB & MBSB kits.
Full details 👉 www.screencell.com/en/news/prod...
#liquidbiopsy #screencell #circulatingtumorcells
Starting Jan 1st: standardized format across our 7 #CTC isolation kits :
✅ 2 filtration units + 1 buffer
Affecting CYTO, CSB, MB & MBSB kits.
Full details 👉 www.screencell.com/en/news/prod...
#liquidbiopsy #screencell #circulatingtumorcells
November 19, 2025 at 10:23 AM
📢 ScreenCell® kits evolving in 2026
Starting Jan 1st: standardized format across our 7 #CTC isolation kits :
✅ 2 filtration units + 1 buffer
Affecting CYTO, CSB, MB & MBSB kits.
Full details 👉 www.screencell.com/en/news/prod...
#liquidbiopsy #screencell #circulatingtumorcells
Starting Jan 1st: standardized format across our 7 #CTC isolation kits :
✅ 2 filtration units + 1 buffer
Affecting CYTO, CSB, MB & MBSB kits.
Full details 👉 www.screencell.com/en/news/prod...
#liquidbiopsy #screencell #circulatingtumorcells
🎥 Have you read our latest article?
We recently published our latest scientific publication in the International Journal of Molecular Sciences MDPI :
📖 "Optimizing #CTC Detection in #BreastCancer: Unveiling Novel Markers for Clinical Applications"
🗓️ Published on May 14, 2025
We recently published our latest scientific publication in the International Journal of Molecular Sciences MDPI :
📖 "Optimizing #CTC Detection in #BreastCancer: Unveiling Novel Markers for Clinical Applications"
🗓️ Published on May 14, 2025
October 21, 2025 at 8:34 AM
🎥 Have you read our latest article?
We recently published our latest scientific publication in the International Journal of Molecular Sciences MDPI :
📖 "Optimizing #CTC Detection in #BreastCancer: Unveiling Novel Markers for Clinical Applications"
🗓️ Published on May 14, 2025
We recently published our latest scientific publication in the International Journal of Molecular Sciences MDPI :
📖 "Optimizing #CTC Detection in #BreastCancer: Unveiling Novel Markers for Clinical Applications"
🗓️ Published on May 14, 2025
📢 Our Chief Scientific Officer, Dr. Georges Uzan, will represent #ScreenCell at the #ELBS 2025 Annual General Meeting in Madrid, Spain 🇪🇸 on Nov 3–4, 2025.
He’ll be on site to exchange with members of the #LiquidBiopsy community and discuss future collaborations.
#CTC
He’ll be on site to exchange with members of the #LiquidBiopsy community and discuss future collaborations.
#CTC
October 16, 2025 at 7:05 AM
📢 Our Chief Scientific Officer, Dr. Georges Uzan, will represent #ScreenCell at the #ELBS 2025 Annual General Meeting in Madrid, Spain 🇪🇸 on Nov 3–4, 2025.
He’ll be on site to exchange with members of the #LiquidBiopsy community and discuss future collaborations.
#CTC
He’ll be on site to exchange with members of the #LiquidBiopsy community and discuss future collaborations.
#CTC
Thanks to @bpifrance-officiel.bsky.social and Mathilde Nourian-Tixier-Perenet for this wonderful showcase of our liquid biopsy technology during #OctobreRose 💗
A fascinating article on the future of cancer and CTC monitoring 👇
bigmedia.bpifrance.fr/nos-actualit...
A fascinating article on the future of cancer and CTC monitoring 👇
bigmedia.bpifrance.fr/nos-actualit...
October 13, 2025 at 12:37 PM
Thanks to @bpifrance-officiel.bsky.social and Mathilde Nourian-Tixier-Perenet for this wonderful showcase of our liquid biopsy technology during #OctobreRose 💗
A fascinating article on the future of cancer and CTC monitoring 👇
bigmedia.bpifrance.fr/nos-actualit...
A fascinating article on the future of cancer and CTC monitoring 👇
bigmedia.bpifrance.fr/nos-actualit...
🎥 Q&A: Emile Lakis, PhD answers your question! #1 👩🔬
You ask us your questions, we answer them 🎯
Today, our Technical Sales Manager answers a frequently asked question:
"Are ScreenCell kits for #circulatingtumorcell #CTC isolation only RUO?"
A question in mind? Leave it in the comments 💭
You ask us your questions, we answer them 🎯
Today, our Technical Sales Manager answers a frequently asked question:
"Are ScreenCell kits for #circulatingtumorcell #CTC isolation only RUO?"
A question in mind? Leave it in the comments 💭
October 9, 2025 at 9:48 AM
🎥 Q&A: Emile Lakis, PhD answers your question! #1 👩🔬
You ask us your questions, we answer them 🎯
Today, our Technical Sales Manager answers a frequently asked question:
"Are ScreenCell kits for #circulatingtumorcell #CTC isolation only RUO?"
A question in mind? Leave it in the comments 💭
You ask us your questions, we answer them 🎯
Today, our Technical Sales Manager answers a frequently asked question:
"Are ScreenCell kits for #circulatingtumorcell #CTC isolation only RUO?"
A question in mind? Leave it in the comments 💭
🎀 #PinkOctober 💗
At ScreenCell®, the fight against cancer is at the heart of our mission.
For Pink October, we're turning all our social media channels pink to show our support for research, patients, caregivers, and all those affected by breast cancer.
#octobrerose2025
At ScreenCell®, the fight against cancer is at the heart of our mission.
For Pink October, we're turning all our social media channels pink to show our support for research, patients, caregivers, and all those affected by breast cancer.
#octobrerose2025
October 1, 2025 at 9:04 AM
🎀 #PinkOctober 💗
At ScreenCell®, the fight against cancer is at the heart of our mission.
For Pink October, we're turning all our social media channels pink to show our support for research, patients, caregivers, and all those affected by breast cancer.
#octobrerose2025
At ScreenCell®, the fight against cancer is at the heart of our mission.
For Pink October, we're turning all our social media channels pink to show our support for research, patients, caregivers, and all those affected by breast cancer.
#octobrerose2025
📸 Thank you #ACTC2025!
🙏 Thank you to everyone who came to chat with us at our booth, participate in our live demonstrations, and attend the oral presentation by our Technical Director, Dr. Sina NASERIAN.
We look forward to seeing you at the 8th edition of ACTC!
🙏 Thank you to everyone who came to chat with us at our booth, participate in our live demonstrations, and attend the oral presentation by our Technical Director, Dr. Sina NASERIAN.
We look forward to seeing you at the 8th edition of ACTC!
September 29, 2025 at 8:53 AM
📸 Thank you #ACTC2025!
🙏 Thank you to everyone who came to chat with us at our booth, participate in our live demonstrations, and attend the oral presentation by our Technical Director, Dr. Sina NASERIAN.
We look forward to seeing you at the 8th edition of ACTC!
🙏 Thank you to everyone who came to chat with us at our booth, participate in our live demonstrations, and attend the oral presentation by our Technical Director, Dr. Sina NASERIAN.
We look forward to seeing you at the 8th edition of ACTC!
📢 #ACTC2025 continues until tomorrow!
✨ Don't miss our oral presentation today, from 3:00 PM to 3:20 PM, where we will demonstrate our #CTCisolationtechnology and share our latest clinical data on the uses of circulating tumor cells #CTCs in a routine clinical setting.
✨ Don't miss our oral presentation today, from 3:00 PM to 3:20 PM, where we will demonstrate our #CTCisolationtechnology and share our latest clinical data on the uses of circulating tumor cells #CTCs in a routine clinical setting.
September 26, 2025 at 7:40 AM
📢 #ACTC2025 continues until tomorrow!
✨ Don't miss our oral presentation today, from 3:00 PM to 3:20 PM, where we will demonstrate our #CTCisolationtechnology and share our latest clinical data on the uses of circulating tumor cells #CTCs in a routine clinical setting.
✨ Don't miss our oral presentation today, from 3:00 PM to 3:20 PM, where we will demonstrate our #CTCisolationtechnology and share our latest clinical data on the uses of circulating tumor cells #CTCs in a routine clinical setting.
🎉 #ACTC2025 kicks off today on #WorldCancerResearchDay !
📍 Find us at booth #1 to discover our CTC isolation technology, exchange with our team, and even take part in live demonstrations.
📍 Find us at booth #1 to discover our CTC isolation technology, exchange with our team, and even take part in live demonstrations.
September 24, 2025 at 8:32 AM
🎉 #ACTC2025 kicks off today on #WorldCancerResearchDay !
📍 Find us at booth #1 to discover our CTC isolation technology, exchange with our team, and even take part in live demonstrations.
📍 Find us at booth #1 to discover our CTC isolation technology, exchange with our team, and even take part in live demonstrations.
Our CTO, Dr. Sina NASERIAN, will be speaking at an oral presentation at the #ACTC2025!
📍 ScreenCell® Technology: Tailored and Cost-Effective CTC Analysis Platform Meeting Clinical Oncology Needs
🗓️ September 26th
⏰ 15:00 to 15:20
Visit us at stand #1
📍 ScreenCell® Technology: Tailored and Cost-Effective CTC Analysis Platform Meeting Clinical Oncology Needs
🗓️ September 26th
⏰ 15:00 to 15:20
Visit us at stand #1
September 18, 2025 at 9:07 AM
Our CTO, Dr. Sina NASERIAN, will be speaking at an oral presentation at the #ACTC2025!
📍 ScreenCell® Technology: Tailored and Cost-Effective CTC Analysis Platform Meeting Clinical Oncology Needs
🗓️ September 26th
⏰ 15:00 to 15:20
Visit us at stand #1
📍 ScreenCell® Technology: Tailored and Cost-Effective CTC Analysis Platform Meeting Clinical Oncology Needs
🗓️ September 26th
⏰ 15:00 to 15:20
Visit us at stand #1
What if you could isolate #circulatingtumorcells (#CTCs) faster than reading a scientific publication? 📖
With our single-use isolation devices, isolate your CTCs using #liquidbiopsy in less than 10 minutes, with a recovery rate greater than 90%. ⚡
With our single-use isolation devices, isolate your CTCs using #liquidbiopsy in less than 10 minutes, with a recovery rate greater than 90%. ⚡
September 16, 2025 at 9:06 AM
What if you could isolate #circulatingtumorcells (#CTCs) faster than reading a scientific publication? 📖
With our single-use isolation devices, isolate your CTCs using #liquidbiopsy in less than 10 minutes, with a recovery rate greater than 90%. ⚡
With our single-use isolation devices, isolate your CTCs using #liquidbiopsy in less than 10 minutes, with a recovery rate greater than 90%. ⚡
ScreenCell at ACTC 2025 – Booth #1 ✨
We are proud to announce our participation as an exhibitor at the 7th ACTC, which will be held in Thessaloniki, Greece, from September 24-27, 2025, organized by Evi Lianidou and Hellenic Society of Liquid Biopsy.
We are proud to announce our participation as an exhibitor at the 7th ACTC, which will be held in Thessaloniki, Greece, from September 24-27, 2025, organized by Evi Lianidou and Hellenic Society of Liquid Biopsy.
September 11, 2025 at 11:34 AM
ScreenCell at ACTC 2025 – Booth #1 ✨
We are proud to announce our participation as an exhibitor at the 7th ACTC, which will be held in Thessaloniki, Greece, from September 24-27, 2025, organized by Evi Lianidou and Hellenic Society of Liquid Biopsy.
We are proud to announce our participation as an exhibitor at the 7th ACTC, which will be held in Thessaloniki, Greece, from September 24-27, 2025, organized by Evi Lianidou and Hellenic Society of Liquid Biopsy.
🎗 World Lung Cancer Day
Lung cancer is the most common cancer worldwide, with 2.5M new cases/year.
It can strike anyone, anytime, silently.
🔬 Discover our #CTC research & that of our partners:
www.screencell.com/en/scientifi...
Lung cancer is the most common cancer worldwide, with 2.5M new cases/year.
It can strike anyone, anytime, silently.
🔬 Discover our #CTC research & that of our partners:
www.screencell.com/en/scientifi...
August 1, 2025 at 9:28 AM
🎗 World Lung Cancer Day
Lung cancer is the most common cancer worldwide, with 2.5M new cases/year.
It can strike anyone, anytime, silently.
🔬 Discover our #CTC research & that of our partners:
www.screencell.com/en/scientifi...
Lung cancer is the most common cancer worldwide, with 2.5M new cases/year.
It can strike anyone, anytime, silently.
🔬 Discover our #CTC research & that of our partners:
www.screencell.com/en/scientifi...
🩸"Health is priceless!" 💵
Do you agree with this statement?
“If health is priceless, it still comes at a cost.” And we’re fully aware of that.
Do you agree with this statement?
“If health is priceless, it still comes at a cost.” And we’re fully aware of that.
July 29, 2025 at 9:06 AM
🩸"Health is priceless!" 💵
Do you agree with this statement?
“If health is priceless, it still comes at a cost.” And we’re fully aware of that.
Do you agree with this statement?
“If health is priceless, it still comes at a cost.” And we’re fully aware of that.
🎥 Are you working on circulating tumor cells (#CTCs) and looking to accurately detect mutations? Don't miss the replay of our webinar in collaboration with @stillatechnologies.bsky.social ! 🔬
📩 The replay is now available on-demand: www.screencell.com/en/webinar-s...
#Liquidbiopsy #Oncology
📩 The replay is now available on-demand: www.screencell.com/en/webinar-s...
#Liquidbiopsy #Oncology
July 22, 2025 at 10:02 AM
🎥 Are you working on circulating tumor cells (#CTCs) and looking to accurately detect mutations? Don't miss the replay of our webinar in collaboration with @stillatechnologies.bsky.social ! 🔬
📩 The replay is now available on-demand: www.screencell.com/en/webinar-s...
#Liquidbiopsy #Oncology
📩 The replay is now available on-demand: www.screencell.com/en/webinar-s...
#Liquidbiopsy #Oncology
🔬 Discover every detail of our isolation platform for capturing #circulatingtumorcells using #liquidbiopsy 🩸
Would you like to know how to integrate our technology into your #research project?
Contact us : lnkd.in/edURqtjQ
Would you like to know how to integrate our technology into your #research project?
Contact us : lnkd.in/edURqtjQ
July 16, 2025 at 8:48 AM
🔬 Discover every detail of our isolation platform for capturing #circulatingtumorcells using #liquidbiopsy 🩸
Would you like to know how to integrate our technology into your #research project?
Contact us : lnkd.in/edURqtjQ
Would you like to know how to integrate our technology into your #research project?
Contact us : lnkd.in/edURqtjQ
🩸 Can surgery promote the spread of circulating tumor cells (CTCs)?
In non-small cell lung cancer (NSCLC), researchers using our technology detected more CTCs after surgery, which is associated with a higher risk of recurrence five years later.
In non-small cell lung cancer (NSCLC), researchers using our technology detected more CTCs after surgery, which is associated with a higher risk of recurrence five years later.
July 9, 2025 at 3:13 PM
🩸 Can surgery promote the spread of circulating tumor cells (CTCs)?
In non-small cell lung cancer (NSCLC), researchers using our technology detected more CTCs after surgery, which is associated with a higher risk of recurrence five years later.
In non-small cell lung cancer (NSCLC), researchers using our technology detected more CTCs after surgery, which is associated with a higher risk of recurrence five years later.
🔬 New publication! ScreenCell® technology enhances Circulating Tumor Cell detection in breast cancer using new biomarkers 🧬
📖 Published May 14, 2025
📎 www.mdpi.com/1422-0067/26...
Led by Sina NASERIAN and Amira Mehtar, in collaboration with Inserm and Kahia/Genethical Lab in Algeria.
📖 Published May 14, 2025
📎 www.mdpi.com/1422-0067/26...
Led by Sina NASERIAN and Amira Mehtar, in collaboration with Inserm and Kahia/Genethical Lab in Algeria.
www.mdpi.com
May 21, 2025 at 7:54 AM
🔬 New publication! ScreenCell® technology enhances Circulating Tumor Cell detection in breast cancer using new biomarkers 🧬
📖 Published May 14, 2025
📎 www.mdpi.com/1422-0067/26...
Led by Sina NASERIAN and Amira Mehtar, in collaboration with Inserm and Kahia/Genethical Lab in Algeria.
📖 Published May 14, 2025
📎 www.mdpi.com/1422-0067/26...
Led by Sina NASERIAN and Amira Mehtar, in collaboration with Inserm and Kahia/Genethical Lab in Algeria.